Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer
Clinical trial NCT02168777 · TERMINATED
Trial details
- NCT number
- NCT02168777
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-23
- Primary completion
- 2015-10-23
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.